Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy

High-sensitivity ctDNA assays to detect low-burden disease

Date

17 Oct 2020

Session

Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy

Topics

Translational Research

Tumour Site

Presenters

Nitzan Rosenfeld

Authors

N. Rosenfeld

Author affiliations

Cancer Research UK Cambridge Institute, CB2 0RE - Cambridge/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

17 Oct 2020

cfDNA in CNS tumours

Presenter: Joan Seoane

Session: Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy

Resources:

Slides

Webcast

17 Oct 2020

Cell-free DNA methylomes and early-stage cancers

Presenter: Daniel De Carvalho

Session: Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy

Resources:

Slides

Webcast

17 Oct 2020

Leveraging mutational signatures for mutational calling in cell-free tumour DNA

Presenter: Dan Landau

Session: Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy

Resources:

Slides

Webcast

17 Oct 2020

Q&A and live discussion

Presenter: Dan Landau

Session: Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy

Resources:

Webcast